// App-Quantinova.ai

P03.08 : INHIBITION OF CASEIN KINASE II (CK2) ENHANCES IKAROS TUMOR SUPPRESSOR ACTIVITY AND SHOWS THERAPEUTIC EFFICACY IN A PRECLINICAL LEUKEMIA MODEL

Researchers

Presenter

  • S. Dovat

Principal Investigators

  • C. Song

  • C. Gowda

  • L. Petrovic-Dovat

  • J. Payne

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Casein Kinase II

  • Cyclin dependent kinase 2

Drug/Treatment

  • Casein

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved